Recent Quotes (30 days)

You have no recent quotes
chg | %

Clinigen Group PLC  

(Public, LON:CLIN)   Watch this stock  
+5.02 (0.45%)
Oct 18 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,118.00 - 1,130.00
52 week 695.00 - 1,175.00
Open 1,123.00
Vol / Avg. 290,284.00/307,314.00
Mkt cap 1,297.92M*
P/E 345.20
Div/yield 3.40*
EPS 0.03*
Shares 115.37M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 0.70% 1.26%
Operating margin 6.14% 5.19%
EBITD margin - 21.27%
Return on average assets 0.53% 0.83%
Return on average equity 0.98% 1.57%
Employees 498 -
CDP Score - -


Pitcairn House Crown Square, First Avenue
United Kingdom - Map
+44-1283-495010 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Officers and directors

Shaun Edward Chilton Chief Executive Officer, Director
Age: 46
Martin James Abell Chief Financial Officer - Elect, Director
Age: 41
Peter Vance Allen Independent Non-Executive Chairman of the Board
Age: 58
John Bacon Non-Executive Director
Peter Lutz George Non-Executive Director
John Hartup Independent Non-Executive Director
Ian J. Nicholson Independent Non-Executive Director
Age: 54